NEVONSA Trademark

Trademark Overview


On Thursday, December 18, 2014, a trademark application was filed for NEVONSA with the United States Patent and Trademark Office. The USPTO has given the NEVONSA trademark a serial number of 79164342. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, July 11, 2018. This trademark is owned by Novartis AG. The NEVONSA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-inf...
nevonsa

General Information


Serial Number79164342
Word MarkNEVONSA
Filing DateThursday, December 18, 2014
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, July 11, 2018
Registration Number4839021
Registration DateTuesday, October 27, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 11, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateWednesday, July 11, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH-4002 Basel
CH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH-4002 Basel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH-4002 Basel
CH

Trademark Events


Event DateEvent Description
Saturday, January 26, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, January 26, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, April 29, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, March 16, 2016FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, March 16, 2016FINAL DISPOSITION PROCESSED
Wednesday, January 27, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 27, 2015REGISTERED-PRINCIPAL REGISTER
Friday, August 21, 2015NOTIFICATION PROCESSED BY IB
Tuesday, August 11, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 11, 2015PUBLISHED FOR OPPOSITION
Wednesday, August 5, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 5, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 22, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 7, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 6, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 17, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 4, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 17, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 12, 2015REFUSAL PROCESSED BY IB
Tuesday, June 9, 2015ASSIGNED TO LIE
Thursday, June 4, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 3, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 3, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, May 9, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, May 9, 2015REFUSAL PROCESSED BY MPU
Saturday, May 9, 2015APPLICATION FILING RECEIPT MAILED
Friday, May 8, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, May 7, 2015NON-FINAL ACTION WRITTEN
Tuesday, May 5, 2015ASSIGNED TO EXAMINER
Tuesday, May 5, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 4, 2015LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, April 30, 2015SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB